The use of preliminary scientific evidence in public health: a case study of XMRV.

The use of preliminary scientific evidence in public health: a case study of XMRV.

Kumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disprov...

Full description

Bibliographic Details
Main Authors: Kumanan Wilson, Katherine Atkinson, Jennifer Keelan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-04-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC3979645?pdf=render
id doaj-7fb121f46968460eb398dcd24435dfec
record_format Article
spelling doaj-7fb121f46968460eb398dcd24435dfec2020-11-25T02:32:46ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762014-04-01114e100162310.1371/journal.pmed.1001623The use of preliminary scientific evidence in public health: a case study of XMRV.Kumanan WilsonKatherine AtkinsonJennifer KeelanKumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disproven and retracted from the peer-reviewed literature, which creates a challenge for regulators and scientific journals. Please see later in the article for the Editors' Summary.http://europepmc.org/articles/PMC3979645?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kumanan Wilson
Katherine Atkinson
Jennifer Keelan
spellingShingle Kumanan Wilson
Katherine Atkinson
Jennifer Keelan
The use of preliminary scientific evidence in public health: a case study of XMRV.
PLoS Medicine
author_facet Kumanan Wilson
Katherine Atkinson
Jennifer Keelan
author_sort Kumanan Wilson
title The use of preliminary scientific evidence in public health: a case study of XMRV.
title_short The use of preliminary scientific evidence in public health: a case study of XMRV.
title_full The use of preliminary scientific evidence in public health: a case study of XMRV.
title_fullStr The use of preliminary scientific evidence in public health: a case study of XMRV.
title_full_unstemmed The use of preliminary scientific evidence in public health: a case study of XMRV.
title_sort use of preliminary scientific evidence in public health: a case study of xmrv.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2014-04-01
description Kumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disproven and retracted from the peer-reviewed literature, which creates a challenge for regulators and scientific journals. Please see later in the article for the Editors' Summary.
url http://europepmc.org/articles/PMC3979645?pdf=render
work_keys_str_mv AT kumananwilson theuseofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
AT katherineatkinson theuseofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
AT jenniferkeelan theuseofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
AT kumananwilson useofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
AT katherineatkinson useofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
AT jenniferkeelan useofpreliminaryscientificevidenceinpublichealthacasestudyofxmrv
_version_ 1724817901386465280

Similar Items